{"pub": "cnn", "url": "https://cnn.com/2019/09/23/health/fda-voluntary-recall-blood-pressure-drugs/index.html", "downloaded_at": "2019-09-24 13:55:34.917182+00:00", "title": "The FDA expands recall of blood pressure drugs again", "language": "en", "text": "(CNN) Torrent Pharmaceuticals Ltd. has expanded its voluntary recall of two blood pressure medications after trace amounts of a potentially cancer-causing impurity were found during testing.\n\nThe recall affects Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets.\n\nTests of some of those medications revealed amounts of N-methylnitrosobutyric acid (NMBA) that were above the US Food and Drug Administration's daily acceptable levels.\n\nThis recall is related to the valsartan recall that has been expanded multiple times since July, when separate lots of blood pressure medications from different companies began being pulled from pharmacy shelves.\n\nThe medications all contained either valsartan, losartan or irbesartan and had traces of these impurities that pose a cancer risk to users.\n\nRead More", "description": "Torrent Pharmaceuticals Ltd. has expanded its voluntary recall of two blood pressure medications after trace amounts of a potentially cancer-causing impurity were found during testing.", "authors": ["Nadia Kounang", "Jen Christensen", "Debra Goldschmidt"], "top_image": "https://cdn.cnn.com/cnnnext/dam/assets/111107161021-blood-pressure-super-tease.jpg", "published_at": "2019-09-23"}